Jove
Visualize
Contact Us

Related Experiment Videos

[Amiodarone-induced bilateral optic atrophy--a case report].

R Gobbelé1, C Dahlke, M Mull

  • 1Klinik für Neurologie, RWTH, Aachen.

Der Nervenarzt
|July 21, 1999
PubMed
Summary

Amiodarone, an antiarrhythmic drug, can cause toxic optic neuropathy leading to visual loss. This rare side effect requires careful diagnosis, especially when differentiating from other causes of vision problems.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Outcome of Patients with Spinal Dural Arteriovenous Fistula: The Dilemma of Delayed Diagnosis.

AJNR. American journal of neuroradiology·2020
Same author

Treatment strategy and long-term outcome in patients with deep lumbosacral arteriovenous fistulas. A single center analysis in nineteen patients.

Clinical neurology and neurosurgery·2019
Same author

PDE10A mutation in two sisters with a hyperkinetic movement disorder - Response to levodopa.

Parkinsonism & related disorders·2019
Same author

The clinical value of venous drainage in patients with spinal dural arteriovenous fistula.

Journal of the neurological sciences·2018
Same author

Double spinal dural arteriovenous fistulas.

Journal of neuroradiology = Journal de neuroradiologie·2018
Same author

Spinal Epidural Arteriovenous Fistula with Perimedullary Venous Reflux: Clinical and Neuroradiologic Features of an Underestimated Vascular Disorder.

AJNR. American journal of neuroradiology·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Ophthalmology
  • Cardiology
  • Neurology

Background:

  • Amiodarone is a crucial antiarrhythmic medication for managing severe cardiac arrhythmias.
  • Its known side effects include ceratopathy and neuropathy due to its cationic amphiphilic nature.

Observation:

  • A patient experienced visual loss and bilateral papilledema while undergoing amiodarone therapy.
  • Intracranial hypertension, tumors, and inflammation were ruled out as potential causes.

Findings:

  • The observed symptoms are consistent with amiodarone-induced toxic optic neuropathy.
  • This condition is rarely described, posing diagnostic challenges.

Implications:

  • Highlights the importance of considering amiodarone toxicity in patients with unexplained visual disturbances.

Related Experiment Videos

  • Underscores the need for further research into the pathophysiology and management of amiodarone-induced optic neuropathy.